Socioeconomic disparities in the utilization of spinal cord stimulation therapy in patients with chronic pain

By Orhurhu V, Gao C, Agudile E, et al
Published August 26, 2020

Key Takeaways

Patients with complex regional pain syndrome I (CRPS I) and failed back surgery syndrome (FBSS) are managed using spinal cord stimulation (SCS) therapies. Researchers here examined if SCS therapy in these patients differ by race and health insurance status. Using the National Inpatient Sample database, they identified 40,858 patients who were hospitalized with a primary diagnosis of FBSS and/or CRPS I. A history of SCS therapy was reported in 1,082 (2.7%) of these patients. Observations indicate a possible presence of socioeconomic disparities in the utilization of SCS among hospitalized patients with CRPS I and FBSS the United States. Black and Hispanic patients had higher odds of having SCS therapy relative to White patients. In addition, odds of having SCS therapy were significantly higher for patients with private insurance vs those with Medicare. Furthermore, Medicaid patients had lower odds of having SCS therapy relative to patients with Medicare.  

Read the full article on Pain Practice.

Share with emailShare to FacebookShare to LinkedInShare to Twitter